Tacrolimus-resistant SARS-CoV-2-specific T cell products to prevent and treat severe COVID-19 in immunosuppressed patients-Reference-Cited by-同舟云学术

Tacrolimus-resistant SARS-CoV-2-specific T cell products to prevent and treat severe COVID-19 in immunosuppressed patients

Published:2022-06 Issue: Volume:25 Page:52-73
ISSN:2329-0501
Container-title:Molecular Therapy - Methods & Clinical Development
language:en
Short-container-title:Molecular Therapy - Methods & Clinical Development

Author:

Peter Lena,Wendering Désirée Jacqueline,Schlickeiser Stephan,Hoffmann Henrike,Noster Rebecca,Wagner Dimitrios Laurin,Zarrinrad Ghazaleh,Münch Sandra,Picht Samira,Schulenberg Sarah,Moradian Hanieh,Mashreghi Mir-Farzin,Klein Oliver,Gossen Manfred,Roch Toralf,Babel Nina,Reinke Petra,Volk Hans-Dieter,Amini Leila,Schmueck-Henneresse Michael^ORCID

Publisher

Elsevier BV

Subject

Genetics,Molecular Biology,Molecular Medicine

Reference131 articles.

1. Clinical features of 85 fatal cases of COVID-19 from Wuhan: a retrospective observational study;Du;Am. J. Respir. Crit. Care Med.,2020

2. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention;Wu;J. Am. Med. Assoc.,2020

3. COVID-19 mortality in transplant recipients;Alfishawy;Int. J. Organ Transpl. Med.,2020

4. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry;Gianfrancesco;Ann. Rheum. Dis.,2020

5. T cells: warriors of SARS-CoV-2 infection;de Candia;Trends Immunol.,2021

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A phase I/II study of adoptive SARS-CoV-2-specific T cells in immunocompromised hosts with or at risk of severe COVID-19 infection;Cytotherapy;2024-05

2. Experience in manufacturing a haploidentical biomedical cell product enriched with regulatory T-lymphocytes;Pediatric Hematology/Oncology and Immunopathology;2024-04-08

3. The Natural History of SARS-CoV-2-Incurred Disease: From Infection to Long COVID;International Journal of Translational Medicine;2024-01-08

4. Immunologic response and seroconversion following third-dose COVID-19 vaccination in solid organ transplant recipients: A meta-analysis;Transplant Immunology;2023-10

5. Engineering immunosuppressive drug-resistant armored (IDRA) SARS-CoV-2 T cells for cell therapy;Cellular & Molecular Immunology;2023-09-05